Global Alzheimer’s Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 154971
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 118
  • list Chemicals and Materials

Scope of the Report:

This report focuses on the Alzheimer’s Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Alzheimer’s Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Ono Pharmaceutical

Johnson & Johnson

Daiichi Sankyo Company Limited

H Lundbeck A/S

Eisai Co Ltd.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Cholinergic

Memantine

Combined Drug 

Market Segment by Applications, can be divided into

Hospital Pharmacy

Retail Pharmacy

Online Sales

There are 15 Chapters to deeply display the global Alzheimer’s Drugs market.

Chapter 1, to describe Alzheimer’s Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Alzheimer’s Drugs, with sales, revenue, and price of Alzheimer’s Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Alzheimer’s Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Alzheimer’s Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Alzheimer’s Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Alzheimer’s Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Cholinergic

1.2.2 Memantine

1.2.3 Combined Drug 

1.3 Market Analysis by Applications

1.3.1 Hospital Pharmacy

1.3.2 Retail Pharmacy

1.3.3 Online Sales

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Ono Pharmaceutical

2.1.1 Business Overview

2.1.2 Alzheimer’s Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Ono Pharmaceutical Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Johnson & Johnson

2.2.1 Business Overview

2.2.2 Alzheimer’s Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Johnson & Johnson Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Daiichi Sankyo Company Limited

2.3.1 Business Overview

2.3.2 Alzheimer’s Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Daiichi Sankyo Company Limited Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 H Lundbeck A/S

2.4.1 Business Overview

2.4.2 Alzheimer’s Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 H Lundbeck A/S Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Eisai Co Ltd.

2.5.1 Business Overview

2.5.2 Alzheimer’s Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Eisai Co Ltd. Alzheimer’s Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Alzheimer’s Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Alzheimer’s Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Alzheimer’s Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Alzheimer’s Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Alzheimer’s Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Alzheimer’s Drugs Market Analysis by Regions

4.1 Global Alzheimer’s Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Alzheimer’s Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Alzheimer’s Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

4.5 South America Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

5 North America Alzheimer’s Drugs by Countries

5.1 North America Alzheimer’s Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Alzheimer’s Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Alzheimer’s Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

6 Europe Alzheimer’s Drugs by Countries

6.1 Europe Alzheimer’s Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Alzheimer’s Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Alzheimer’s Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

6.3 UK Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

6.4 France Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Alzheimer’s Drugs by Countries

7.1 Asia-Pacific Alzheimer’s Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Alzheimer’s Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Alzheimer’s Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

7.5 India Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

8 South America Alzheimer’s Drugs by Countries

8.1 South America Alzheimer’s Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Alzheimer’s Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Alzheimer’s Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Alzheimer’s Drugs by Countries

9.1 Middle East and Africa Alzheimer’s Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Alzheimer’s Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Alzheimer’s Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Alzheimer’s Drugs Sales and Growth Rate (2013-2018)

10 Global Alzheimer’s Drugs Market Segment by Type

10.1 Global Alzheimer’s Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Alzheimer’s Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Alzheimer’s Drugs Revenue and Market Share by Type (2013-2018)

10.2 Cholinergic Sales Growth and Price

10.2.1 Global Cholinergic Sales Growth (2013-2018)

10.2.2 Global Cholinergic Price (2013-2018)

10.3 Memantine Sales Growth and Price

10.3.1 Global Memantine Sales Growth (2013-2018)

10.3.2 Global Memantine Price (2013-2018)

10.4 Combined Drug  Sales Growth and Price

10.4.1 Global Combined Drug  Sales Growth (2013-2018)

10.4.2 Global Combined Drug  Price (2013-2018)

11 Global Alzheimer’s Drugs Market Segment by Application

11.1 Global Alzheimer’s Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Pharmacy Sales Growth (2013-2018)

11.3 Retail Pharmacy Sales Growth (2013-2018)

11.4 Online Sales Sales Growth (2013-2018)

12 Alzheimer’s Drugs Market Forecast (2018-2023)

12.1 Global Alzheimer’s Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Alzheimer’s Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Alzheimer’s Drugs Market Forecast (2018-2023)

12.2.2 Europe Alzheimer’s Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Alzheimer’s Drugs Market Forecast (2018-2023)

12.2.4 South America Alzheimer’s Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Alzheimer’s Drugs Market Forecast (2018-2023)

12.3 Alzheimer’s Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Alzheimer’s Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Alzheimer’s Drugs Market Share Forecast by Type (2018-2023)

12.4 Alzheimer’s Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Alzheimer’s Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Alzheimer’s Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Alzheimer’s Drugs Picture

Table Product Specifications of Alzheimer’s Drugs

Figure Global Sales Market Share of Alzheimer’s Drugs by Types in 2017

Please fill the form below, to recieve the report sample


+1